TickerFacts.

Stemtech Corp (STEK): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

-$483.6K
Year ended 2025-12-31
-$328.8K
Trailing 12 months to 2026-06-30
2020-12-31: -$278.3K2023-12-31: -$2.04M2024-12-31: -$601.2K2025-12-31: -$483.6K-$483.6K
2020-12-31 Free Cash Flow (USD) 2025-12-31
Period endedFree Cash FlowChange YoYSource filing
2025-12-31-$483.6Kn/m2026-05-29, From 2025-01-01
2024-12-31-$601.2Kn/m2026-05-29, From 2024-01-01
2023-12-31-$2.04Mn/a2025-06-30, From 2023-01-01
No annual figure between 2020-12-31 and 2023-12-31.
2020-12-31-$278.3Kn/a2022-04-01, From 2020-01-01

Free Cash Flow at similar companies

Companies with the same SEC industry code (Wholesale-Drugs, Proprietaries & Druggists' Sundries), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedFree Cash FlowChange YoY
Stemtech Corp (STEK)2025-12-31-$483.6Kn/m
HWH International Inc. (ESYN)2025-12-31-$1.77Mn/m
Cosmos Health Inc. (COSM)2025-12-31-$8.50Mn/m
Nu Skin Enterprises, Inc. (NUS)2025-12-31$46.01M-34.4%
Herbalife Ltd. (HLF)2025-12-31$252.90M+54.8%
Cardinal Health Inc (CAH)2026-06-30$4.53B+144.6%
Cencora, Inc. (COR)2025-09-30$3.21B+7.0%
McKesson Corp (MCK)2026-03-31$5.72B+3.1%

Compare STEK, ESYN, COSM, NUS side by side · Screen every company in Wholesale-Drugs, Proprietaries & Druggists' Sundries ↗